Logo XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. revascularization
Show results for
Products
Services
Software

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Revascularization Articles & Analysis

7 articles found

Development of a Bioartificial Vascular Pancreas

Development of a Bioartificial Vascular Pancreas

This can lead to islet death during the early post-transplant period before revascularization of transplanted islets by the host. Islets transplanted into the portal vein of the liver using the Edmonton Protocol, where the pO2 of the portal blood is often near 40 mmHg, face local hypoxia as well as acute thrombosis around the islets. ...

ByHumacyte, Inc.


Clinical implementation of the Humacyte human acellular vessel: Implications for military and civilian trauma care

Clinical implementation of the Humacyte human acellular vessel: Implications for military and civilian trauma care

The operative approach to vascular injury has been transformed since World War II when ligation (and often amputation) was the dictum.5 Reports from the recent wars show that some type of revascularization is now pursued in more than half of cases, and that early limb salvage is nearly 90%.2,3,6,7 While the principles of vessel ligation and of “life over limb” are ...

ByHumacyte, Inc.


Health Tech: Dan Rose on How LimFlow’s Technology can Make an Important Impact on our Overall Wellness

Health Tech: Dan Rose on How LimFlow’s Technology can Make an Important Impact on our Overall Wellness

But we choose to initially focus on a reasonably narrow indication (patients with no other options for revascularization) where we can prove the system works. Once that is achieved, we can then work on future technology iterations and clinical trials to grow to our fullest potential. ...

ByLimFlow, Inc.


Cost-Effectiveness of Percutaneous Deep Vein Arterialization for Patients with No-Option Chronic Limb-Threatening Ischemia: an Exploratory Analysis Based on the PROMISE I Study

Cost-Effectiveness of Percutaneous Deep Vein Arterialization for Patients with No-Option Chronic Limb-Threatening Ischemia: an Exploratory Analysis Based on the PROMISE I Study

Treatment of CLTI focuses on revascularization to relieve ischemic rest pain and heal ischemic ulceration or gangrene. ...

ByLimFlow, Inc.


LimFlow Percutaneous Deep Venous Arterialization

LimFlow Percutaneous Deep Venous Arterialization

They were vetted by an independent panel of vascular specialists to confirm that they had no revascularization option other than the LimFlow procedure. No other trial looking at treating patients with no alternatives to standard revascularization techniques has had an independent panel confirming this status. ...

ByLimFlow, Inc.


Innovation Spotlight: Alucent Biomedical | Can we Make ‘Stents’ Obsolete?

Innovation Spotlight: Alucent Biomedical | Can we Make ‘Stents’ Obsolete?

The primary endpoints are freedom from all-cause mortality, target limb major amputation and target lesion revascularization and AlucentNVS drug plasma concentrations. We are also in the process of finalizing the protocol for a larger IDE clinical trial with our intended commercial AlucentNVS system. ...

ByAlucent Biomedical Inc.


The Evolving Role of Percutaneous Deep Venous Arterialization

The Evolving Role of Percutaneous Deep Venous Arterialization

Some patients develop this condition after embolization or failed repeat revascularization attempts; however, most no-option CLTI patients today are affected by small artery disease (SAD). ...

ByLimFlow, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About XPRT Media

XPRT is a global industry marketplace and information resource. Online product catalogs, news, articles, events, publications & more.


  • FAQs
  • Company sitemap
  • Category sitemap
XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
Medical XPRT